Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Pharming Group N.V. Sponsored ADR (PHAR) had Consolidated Net Income/Loss of $-14.89M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$79.09M |
|
$-14.72M |
|
$8.32M |
|
$70.77M |
|
$86.14M |
|
$-7.04M |
|
$-4.74M |
|
$-11.79M |
|
$-11.79M |
|
$-14.89M |
|
$-14.89M |
|
|
Consolidated Net Income/Loss |
$-14.89M |
$-14.89M |
|
$-7.04M |
|
$-4.46M |
|
66.90M |
|
66.90M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$214.11M |
|
$7.77M |
|
$189.07M |
|
$403.18M |
|
$77.54M |
|
$83.85M |
|
$110.36M |
|
$187.89M |
|
$215.29M |
|
$76.43M |
|
$215.29M |
|
-- |
|
| Cash Flow Statement Financials | |
$0.23M |
|
$9.69M |
|
$-6.72M |
|
$54.94M |
|
$60.09M |
|
$5.15M |
|
$2.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
0.28 |
|
0.41 |
|
89.48% |
|
-8.91% |
|
-8.91% |
|
-- |
|
-14.90% |
|
-18.61% |
|
$-0.05M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.14 |
|
1.67 |
|
54.03 |
|
-6.92% |
|
-19.48% |
|
-3.69% |
|
-4.98% |
|
-- |
|
$-0.00 |
|
$0.00 |
|